NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 41 filers reported holding NEUROPACE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,349,237 | +120.5% | 2,399,716 | +1.7% | 0.00% | +100.0% |
Q2 2023 | $10,591,308 | +1.1% | 2,358,866 | +4.5% | 0.00% | 0.0% |
Q1 2023 | $10,477,194 | +221.3% | 2,258,016 | +3.2% | 0.00% | – |
Q4 2022 | $3,261,004 | -59.0% | 2,188,593 | +3.1% | 0.00% | -100.0% |
Q3 2022 | $7,963,000 | -19.0% | 2,123,603 | +7.0% | 0.00% | 0.0% |
Q2 2022 | $9,826,000 | +15.5% | 1,985,189 | +91.7% | 0.00% | 0.0% |
Q1 2022 | $8,504,000 | +216.8% | 1,035,784 | +289.1% | 0.00% | – |
Q4 2021 | $2,684,000 | +2118.2% | 266,228 | +3376.5% | 0.00% | – |
Q3 2021 | $121,000 | -33.1% | 7,658 | +0.9% | 0.00% | – |
Q2 2021 | $181,000 | – | 7,592 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KCK LTD. | 5,621,111 | $27,824,000 | 39.09% |
Revelation Capital Management, LLC | 248,127 | $1,228,000 | 17.38% |
Soleus Capital Management, L.P. | 2,334,003 | $11,553,000 | 1.80% |
Orbimed Advisors | 4,012,281 | $19,861,000 | 0.36% |
Opaleye Management Inc. | 90,100 | $446,000 | 0.20% |
Nantahala Capital Management | 478,438 | $2,368,000 | 0.12% |
Bellevue Group AG | 507,930 | $2,514,000 | 0.04% |
Ergoteles LLC | 34,800 | $172,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 26,148 | $129,000 | 0.00% |
Point72 Asset Management, L.P. | 149,199 | $739,000 | 0.00% |